Icon

VRAYLAR (nda204370)- (EQ 1.5MG BASE,EQ 3MG BASE,EQ 4.5MG BASE,EQ 6MG BASE)

CARIPRAZINE HYDROCHLORIDE ABBVIE
EQ 1.5MG BASE,EQ 3MG BASE,EQ 4.5MG BASE,EQ 6MG BASE
Yes No
2029-Sep-17 2020-Sep-17
None None
None No
VRAYLAR is an atypical antipsychotic indicated for:  Treatment of schizophrenia in adults  Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults  Treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults  Adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults
1 1 0
Total Other Developers 22
Drugs with Suitability No
EQ 1.5MG BASE ** ** Up - -
EQ 3MG BASE ** ** Up - -
EQ 4.5MG BASE ** ** Up - -
EQ 6MG BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.